Anne-Marie
Anne Marie Biernacki, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20140316797 | Methods and system for evaluating medication regimen using risk assessment and reconciliation - Computer-based and network-based methods and system that provide for evaluating medication regimen using medication-related risk assessment in an automated medication reconciliation process can comprise, without limitation, collecting comprehensive information with respect to a patient that can fill in gaps typical of claims, EHR, or HIE-based data sets, based on curated clinician review and annotation or tagging of data. Various embodiments introduce flexible use of a variety of accurate and efficient methods for capturing and characterizing medications in point-of-care settings, including structured interviews, bar code scanning, and image recognition. Embodiments of the invention can further provide for harmonizing and reconciling data from disparate sources, calculating risk based on a more comprehensive assessment and annotation of the data sets and comparing risk to create a risk offset or differential, with a subsequent tailoring of interventions based on the risk offset or differential. | 10-23-2014 |
Anne Marie Ciprari, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20140283551 | BAND ACCESSORY - A band accessory includes, in one embodiment, a base strap, an accessory strap with at least one distal hole, and at least one hook removably securing the accessory strap to the base strap. | 09-25-2014 |
Anne Marie Degraff, Fort Lupton, CO US
Patent application number | Description | Published |
---|---|---|
20110228911 | METHOD FOR DETERMINING TERMINATION OF AN EMERGENCY SERVICE CALL - A method for determining termination of an emergency service call; the emergency service call being connected with an emergency service answering entity in an emergency service network employing a locating unit for ascertaining a geographic origin for the emergency service call; the method including: (a) presenting a query signal from the emergency service answering entity during the emergency service call soliciting a responsive signal from the locating unit relating to the geographic origin; (b) if the query signal relating to the geographic origin is received by the locating unit, considering that the emergency service call is not terminated; and (c) if no query signal relating to the geographic origin is received by the locating unit, considering that the emergency service call is terminated. | 09-22-2011 |
Anne Marie Homeman, Humlebaek DK
Patent application number | Description | Published |
---|---|---|
20150315118 | METHOD OF PRODUCING INGENOL-3-ANGELATE - The present invention relates to methods of producing ingenol-3-angelate (I) from ingenol (II). | 11-05-2015 |
Anne Marie Horneman, Ballerup DK
Patent application number | Description | Published |
---|---|---|
20130059853 | BIARYL PHOSPHODIESTERASE INHIBITORS - Novel biaryl compounds with phosphodiesterase inhibitory activity of the general formula (I), wherein R1, R2, R3, X, Y, Z | 03-07-2013 |
Anne Marie Horneman, Humlebaek DK
Patent application number | Description | Published |
---|---|---|
20110190282 | NOVEL VEGF-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF - The invention relates to compounds of general formula (I) wherein W, D, E, G, J, L, R | 08-04-2011 |
20120028974 | TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES - The present invention relates to a compound according to formula I, wherein R | 02-02-2012 |
20130177952 | METHOD OF PRODUCING INGENOL-3-ANGELATE - The present invention relates to methods of producing ingenol-3-angelate (I) from ingenol (II). | 07-11-2013 |
Anne Marie Isburgh, Cincinnati, OH US
Patent application number | Description | Published |
---|---|---|
20100153080 | Physics-Based Lifespan Modeling - An embodiment of a method for lifespan modeling for a turbine engine component includes determining a design-phase model of the lifespan of an turbine engine component; fusing the design-phase model with sensor data collected during operation of the turbine engine component to produce an updated model of the lifespan of the turbine engine component; and fusing the updated model with data collected during an inspection of the turbine engine component to produce an overall model of the lifespan of the turbine engine component. Systems for lifespan modeling for a turbine engine component are also provided. | 06-17-2010 |
Anne Marie Ryg, Mantorville, MN US
Patent application number | Description | Published |
---|---|---|
20080215535 | AUTONOMICALLY GENERATING A QUERY IMPLEMENTATION THAT MEETS A DEFINED PERFORMANCE SPECIFICATION - A database query optimizer allows specifying a performance specification for a query. When an access plan is created, the actual performance for executing the query using the access plan is determined and compared to the performance specification for the query. If the actual performance does not satisfy the performance specification for the query, the query optimizer autonomically generates a different access plan to see if the performance improves. If an access plan that meets the performance specification is generated, the new access plan is stored in the access plan cache for the query. If no access plan can be generated that meets the performance specification for the query, the access plan that provided the best performance is selected and stored in the access plan cache for the query. | 09-04-2008 |
20080215536 | AUTONOMICALLY GENERATING A QUERY IMPLEMENTATION THAT MEETS A DEFINED PERFORMANCE SPECIFICATION - A database query optimizer allows specifying a performance specification for a query. When an access plan is created, the actual performance for executing the query using the access plan is determined and compared to the performance specification for the query. If the actual performance does not satisfy the performance specification for the query, the query optimizer autonomically generates a different access plan to see if the performance improves. If an access plan that meets the performance specification is generated, the new access plan is stored in the access plan cache for the query. If no access plan can be generated that meets the performance specification for the query, the access plan that provided the best performance is selected and stored in the access plan cache for the query. | 09-04-2008 |
20080281779 | Query Directives And Access Plan Hints - A query plan modification system and method relate to a database system that includes a cost-based optimizer for generating access plans. The database system also permits a user to view an access plan that has been generated by a particular SQL query and modify the access plan if desired. The user specifies customizations that are associated with the access plan so that when that plan is executed, the customizations are executed as well. Exemplary customizations include specifying an initialization file specific to a query, specifying different implementation methods than those in the original access plan, prohibiting rebuilding of an access plan, and over-riding or ignoring a clause within the query that is used to generate the access plan. | 11-13-2008 |
20080281780 | Query Directives And Access Plan Hints - A query plan modification system and method relate to a database system that includes a cost-based optimizer for generating access plans. The database system also permits a user to view an access plan that has been generated by a particular SQL query and modify the access plan if desired. The user specifies customizations that are associated with the access plan so that when that plan is executed, the customizations are executed as well. Exemplary customizations include specifying an initialization file specific to a query, specifying different implementation methods than those in the original access plan, prohibiting rebuilding of an access plan, and over-riding or ignoring a clause within the query that is used to generate the access plan. | 11-13-2008 |
20090158091 | Intelligent Job Functionality - A method, apparatus, and program product utilize intelligent job functionality to diagnose an error in a computer. After detecting an error in a first job processing a task, and in response to another attempt to perform the task, a job selection algorithm selects a predetermined job in which to perform the task and diagnose the error. The predetermined job can be the first job or a new job associated with a signature that corresponds to the task that experienced the error. The predetermined job can be used to diagnose the error in a debugging session. Alternately, the first job may enter a debug session immediately after experiencing an error. | 06-18-2009 |
Anne Marie Salapatek, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20120316402 | METHOD AND CHAMBER FOR EXPOSURE TO NON-ALLERGIC RHINITIS TRIGGER ENVIRONMENTS - The present invention is a method and chamber for exposure of human subjects to non-allergic rhinitis (“NAR”) trigger environments. The method occurs in a NAR chamber and involves tests that expose subjects to environmental triggers known to induce NAR symptoms. The chamber may be an enclosure capable of housing multiple subjects, constructed to facilitate the NAR tests and/or challenges and operable to create one or more NAR environments within the chamber. A different NAR environment may be required for each test. The chamber may facilitate the creation and containment of a specific NAR environment relating to a NAR test and/or challenge within the chamber for a particular period of time and achieve air-flow therein whereby subjects positioned within the chamber may be exposed to a NAR trigger environment in a virtually consistent manner. NAR tests and challenges may be assessed and the results thereof may be stored, compiled and/or reported. | 12-13-2012 |
20160067133 | METHOD AND CHAMBER FOR EXPOSURE TO NON-ALLERGIC RHINITIS TRIGGER ENVIRONMENTS - The present invention is a method and chamber for exposure of human subjects to non-allergic rhinitis (“NAR”) trigger environments. The method occurs in a NAR chamber and involves tests that expose subjects to environmental triggers known to induce NAR symptoms. The chamber may be an enclosure capable of housing multiple subjects, constructed to facilitate the NAR tests and/or challenges and operable to create one or more NAR environments within the chamber. A different NAR environment may be required for each test. The chamber may facilitate the creation and containment of a specific NAR environment relating to a NAR test and/or challenge within the chamber for a particular period of time and achieve air-flow therein whereby subjects positioned within the chamber may be exposed to a NAR trigger environment in a virtually consistent manner. NAR tests and challenges may be assessed and the results thereof may be stored, compiled and/or reported. | 03-10-2016 |
Anne Marie Shough, New Castle, DE US
Patent application number | Description | Published |
---|---|---|
20130165357 | Lubricant compositions for SI-AL alloy surfaces and methods for using - A lubricant composition including: (A) greater than 50 wt % of a base stock based on the total weight of the composition selected from the group consisting of that of a Group III base oil, a Group IV base oil, and a combination thereof; and (B) one or more additional components. The one or more additional components are selected from the group consisting of: (i) one or more high or medium base carboxylate detergents; (ii) one or more low base carboxylate detergents, wherein the low base carboxylate detergent is present at a level of 0.60 wt % or less based on the total weight of the composition; (iii) one or more low base carboxylate detergents and one or more aromatics-containing base stock(s); and (iv) one or more phenolic detergents. | 06-27-2013 |
Anne Marie Smith, Ancaster CA
Patent application number | Description | Published |
---|---|---|
20160054310 | BIOSENSORS UTILIZING INK JET-PRINTED BIOMOLECULE COMPATIBLE SOL GEL INKS AND USES THEREOF - Novel solid-phase biosensors that utilize ink jet printing of biocompatible sol-gel based inks to create sensor strips are reported herein. Biomolecules and other reagents useful in bioassays to detect, for example, pathogenic microorganisms or toxic substances, are immobilized on a substrate, which can be paper based, by layering these substances between two layers of biomolecule compatible sol gel. The sol gel precursor solutions and solutions of the assay reagents are printed from separate nozzles in a layered approach which avoids clogging of the nozzles by the pre-mature gelling of the sol gel precursor solution. In certain embodiments of the application, a capture agent is used to concentrate a compound to be detected in specific areas on the substrate to facilitate detection. | 02-25-2016 |
Anne Marie Smith, Anoaster CA
Patent application number | Description | Published |
---|---|---|
20120135437 | BIOSENSORS UTILIZING INK JET-PRINTED BIOMOLECULE COMPATIBLE SOL GEL INKS AND USES THEREOF - Novel solid-phase biosensors that utilize ink jet printing of biocompatible sol-gel based inks to create sensor strips are reported herein. Biomolecules and other reagents useful in bioassays to detect, for example, pathogenic microorganisms or toxic substances, are immobilized on a substrate, which can be paper based, by layering these substances between two layers of biomolecule compatible sol gel. The sol gel precursor solutions and solutions of the assay reagents are printed from separate nozzles in a layered approach which avoids clogging of the nozzles by the pre-mature gelling of the sol gel precursor solution. In certain embodiments of the application, a capture agent is used to concentrate a compound to be detected in specific areas on the substrate to facilitate detection. | 05-31-2012 |
Anne Marie Storhecker, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140134661 | THERAPEUTIC MODULATION OF AUTOPHAGY - Methods for screening for modulators of autophagy are disclosed. Methods for identifying genes whose expression inhibits autophagy, as well as genes whose expression promotes autophagy, are disclosed. Also disclosed are methods for identifying compounds that stimulate autophagy, as well as compounds that inhibit autophagy. Cell lines that may be used in the methods of identification are also disclosed. | 05-15-2014 |
Anne Marie Sweeney-Jones, Irondequoit, NY US
Patent application number | Description | Published |
---|---|---|
20130236825 | TONER COMPOSITION WITH CHARGE CONTROL AGENT-TREATED SPACER PARTICLES - Toner particles include a shell and a core, wherein the shell includes charge control agent-treated spacer particles that cause protrusions from the toner particle surface. | 09-12-2013 |
Anne Marie Tuazon, Renton, WA US
Patent application number | Description | Published |
---|---|---|
20140095524 | MANAGING ITEM QUERIES - A network-based service may be provided for facilitating queries for a number of items, such as travel services. A user may submit a query including criteria for determining one or more relevant items. Based on the submitted query, the network-based service may present the user with information regarding the actions of other similar users of the network-based service, such as searches performed by the other users. Based on this information, the user may elect to supplement the current query to conform to the actions for other users. In some embodiments, actions by other users may be based at least in part on a category of the querying user. By presenting actions of similar users, a current user may be enabled to select the most relevant query terms for identifying a desired item. | 04-03-2014 |
Anne Marie Vinsel, Salt Lake City, UT US
Patent application number | Description | Published |
---|---|---|
20120308973 | KIT AND METHOD FOR PROMOTION OF POSITIVE ADJUSTMENT TO ILLNESS AND TRAUMA - A kit for use in promoting a patient's positive adjustment includes a plurality of module units, each module unit containing instructions for coping with a specific stress symptom, and a transitional object having a module unit receiver. The module unit receiver can receive one of the module units and deliver the instructions on the module unit to the patient. A method of promoting positive adjustment includes the steps of providing a patient with a transitional object and a plurality of module units, each module unit containing instructions for coping with a specific stress symptom, identifying a stress symptom, selecting a module unit having instructions for coping with the stress symptom and delivering the instructions on the selected module unit to the patient with the transitional object. | 12-06-2012 |
Anne-Marie Baribeau, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20110053261 | METHODS FOR DETERMINING CORRELATED RESIDUES IN A PROTEIN OR OTHER BIOPOLYMER USING MOLECULAR DYNAMICS - The invention provides methods and systems of determining biopolymer profiles and correlations between structural units (residues) of a biopolymer based on sampling of the conformational space available to the molecule. The correlations between these structural units can further be used to find networks within a biopolymer such as the coupled residue networks in a protein. The invention also provides for designing and engineering biopolymers including polypeptides, nucleic acids and carbohydrates using the information derived from the conformation clustering and subsequent methods described herein. | 03-03-2011 |
Anne-Marie Beausoliel, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20150209352 | NEPRILYSIN INHIBITORS - In one aspect, the invention relates to compounds having the formula I: | 07-30-2015 |
20150210690 | NEPRILYSIN INHIBITORS - In one aspect, the invention relates to compounds having the formula I: | 07-30-2015 |
Anne-Marie Bebak, The Woodlands, TX US
Patent application number | Description | Published |
---|---|---|
20130274041 | Composite Arrow Vane - Disclosed is a composite arrow vane for mounting to a projectile. The composite arrow vane is constructed of a composite material that includes a polymer matrix around structural elements. In some embodiments, the polymer matrix may be a thermoplastic polyurethane. The structural elements compounded into the polymer may be voids, hollow glass beads or just about any structure having a weight per unit volume that is less than the weight per unit volume of the polymer matrix. Advantageously, the composite material allows for reduced dimensions of the composite arrow vane because the increased tensile strength of the material allows for size reductions without significantly compromising vane performance. Similarly, the lighter weight per unit volume of the composite material as compared to a homogeneous polymer allows for increased flight speed of the projectile. | 10-17-2013 |
Anne-Marie Birot, Sainte-Foy-Les-Lyon FR
Patent application number | Description | Published |
---|---|---|
20090151013 | Modified ES cells and ES cell-specific genes - The invention concerns modified avian ES cells, specifically expressing an exogenous gene when they have a pluripotent character. The invention also concerns a nucleic acid and a polypeptide specifically expressed in pluripotent avian cells, and methods for detecting the pluripotent character of cells using said nucleic acid and polypeptide. | 06-11-2009 |
Anne-Marie Bonnot, Paris FR
Patent application number | Description | Published |
---|---|---|
20100154087 | METHOD FOR GROWING A CARBON NANOTUBE ON A NANOMETRIC TIP - The invention relates to a method for the catalytic growth of carbon nanotubes on nanometric tips by chemical vapour deposition assisted by a hot filament, that comprises a first step of applying a preliminary dual-layer coating of cobalt and titanium on said tip, the titanium layer having a thickness of between 0.1 nm and 0.2 nm and cobalt layer having a thickness of between 0.3 nm and 2 nm. | 06-17-2010 |
Anne-Marie Buibish, Churubusco, IN US
Patent application number | Description | Published |
---|---|---|
20130104232 | APPLIQUE PROVIDING A SECURE DEPLOYMENT ENVIRONMENT (SDE) FOR A WIRELESS COMMUNICATIONS DEVICE - A security appliqué provides a secure deployment environment (SDE) for a wireless communications device. The Security appliqué isolates the security features, requirements, and information security boundaries such that no hardware modifications are required to a wireless communications device. Rather, a security module thin client is provided to the wireless communications device to provide the Secure Deployment Environment (SDE). The wireless communications device is coupled to the security appliqué via the standard connection interface. Through the standard connection interface, the security appliqué provides the SDE for the wireless communications device without implementing modifications to the wireless communications device. | 04-25-2013 |
Anne-Marie Bustillo, St. Paul, MN US
Patent application number | Description | Published |
---|---|---|
20140276929 | IMPLANTABLE MEDICAL DEVICES WITH SEPARATE FIXATION MECHANISM - Devices or methods such as for stimulating excitable tissue or sensing physiologic response or other signals that can use separate fixation mechanism is described. An implantable apparatus can include a modular electrostimulation electrode assembly that can include a first module and a second module that can be end user-attachable to each other and end user-detached from each other. The first module can include an electrostimulation electrode fixation support member that can be laid flat against or otherwise conform to a surface of a heart, and can define a centrally located open portal such as for permitting electrode access to the surface of the heart. The second module can include an electrostimulation electrode that can be inserted through the portal of the fixation support member such as to contact the surface of the heart such as to deliver chronic electrostimulation to the heart. | 09-18-2014 |
Anne-Marie Chaze, Nice FR
Patent application number | Description | Published |
---|---|---|
20110011310 | METHOD OF MANUFACTURING A COMPOSITE BASED ON COMPLEXES OF CONTROLLED STABILITY - The method for manufacturing a composite based on complexes of controlled stability over time using a fibrous inorganic matrix having tunnels and one or more organic compounds incorporated into said tunnels includes the following steps: the fibrous inorganic matrix having tunnels and the organic compound or compounds are provided; the fibrous inorganic matrix having tunnels is mixed with the organic compound or compounds so that said organic compound or compounds are incorporated into the tunnels of the fibrous inorganic matrix; the retention of the organic compound or compounds in said tunnels and their release therefrom by heating said mixture obtained, at a chosen temperature for a defined time, are controlled. The invention applies in particular in a preparation intended for cosmetic, pharmacological, nutri-therapeutic and agri-foodstuff, phytosanitary, petroleum or electronic usage or else in paints. | 01-20-2011 |
Anne-Marie Couroux, Eragny Sur Oise FR
Patent application number | Description | Published |
---|---|---|
20120278997 | DYE COMPOSITION COMPRISING A HETEROCYCLIC OXIDATION BASE AND AN INDOLE COUPLER - The subject of the present invention is dye composition for keratin fibres, comprising, in suitable dyeing medium, a coupler of formula (I) or addition salts thereof with an acid a particular cationic or noncationic aminopyrazolopyridine derivative. The composition of the present invention makes it possible in particular to obtain a colouring with varied, intense and/or chromatic, aesthetic and relatively nonselective shades which are highly resistant to the various attacks to which the hair may be subjected. | 11-08-2012 |
Anne-Marie Couroux, Saint-Ouen-L'Amone FR
Patent application number | Description | Published |
---|---|---|
20140259454 | DYE COMPOSITION COMPRISING A HETEROCYCLIC OXIDATION BASE AND A 4-AMINOINDOLE COUPLER - The present invention relates to a composition for dyeing keratin fibres, comprising, in a medium that is suitable for dyeing keratin fibres: at least one oxidation base chosen from 4,5-diaminopyrazole, pyrazolopyrimidine and diamino-N,N-dihydropyrazolone heterocyclic bases, and at least one coupler chosen from the compounds of formula (II) and the addition salts thereof, solvates thereof and solvates of the salts thereof: The composition of the present invention makes it possible in particular to obtain colorations in varied shades, which are strong, chromatic, powerful, aesthetic, sparingly selective and resistant to the various attacking factors to which the hair may be subjected. | 09-18-2014 |
Anne-Marie Couroux, Saint Ouen L'Aumone FR
Patent application number | Description | Published |
---|---|---|
20140007358 | DYE COMPOSITION COMPRISING AT LEAST FOUR DYE PRECURSORS INCLUDING AT LEAST ONE OXIDATION BASE AND AT LEAST ONE COUPLER - The present invention relates to a dye composition comprising at least four oxidation dye precursors, including at least one oxidation base chosen from suitably selected pyrazolopyridines and diamino-N,N-dihydropyrazolone derivatives and at least one coupler chosen from suitably selected cationic 3,5-diaminopyridines and 4-aminoindoles, 5-amino-6-chloro-2-methylphenol, 6-hydroxybenzomorpholine, 2-methyl-5-hydroxyethylaminophenol and 2-amino-3-hydroxypyridine, and also to the dyeing process using this composition. The present invention makes it possible in particular to obtain a composition for dyeing keratin fibres that is suitable for use in oxidation dyeing and that can produce colourations in varied shades, which are strong or chromatic, powerful, aesthetic, sparingly selective, and resistant to the various attacking factors to which the hair may be subjected, such as shampoo, sweat, permanent reshaping and light. The composition in accordance with the invention moreover shows good harmlessness and good stability. | 01-09-2014 |
Anne-Marie Di Guilmi, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20140030286 | PEPTIDES CAPABLE OF FORMING A CONVALENT COMPLEX, AND USES THEREOF - The present invention relates to a peptide capable of forming a covalent complex consisting either of the Jo peptide, a derivative or a fragment thereof, or of the In peptide, a derivative or a fragment thereof. The present invention relates to the various uses thereof. | 01-30-2014 |
Anne-Marie Doisy, Joinville Sur Juine FR
Patent application number | Description | Published |
---|---|---|
20110094470 | COMBUSTION ENGINE COMBUSTION CHAMBER - A piston for an internal combustion engine, for example a diesel engine, including a body delimited laterally by a skirt and configured to collaborate with walls of a cylinder of axis of revolution C in which the piston can slide along the axis C, the piston including a transverse face including a central pip, a peripheral ring, and a bowl of axis of revolution B that extends from the central pip towards the peripheral ring to which it connects at a lip of thickness Ep, the bowl including, in substantial vertical alignment with the lip, a torus in profile, for example of dome-shaped, of maximum radius capable of guiding fuel injected under the lip in the region of a re-entrant zone towards the central pip. The tip of the central pip exhibits a flattened region centred on the axis of revolution B of the bowl, of a width Lt ranging between 0 mm and 5 mm, or substantially equal to 2.5 mm. | 04-28-2011 |
Anne-Marie Duliege, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20090118183 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. | 05-07-2009 |
20090136442 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. | 05-28-2009 |
20090209457 | TREATMENT OF ANTI-ERYTHROPOIETIN ANTIBODY-MEDIATED DISORDERS WITH SYNTHETIC PEPTIDE-BASED EPO RECEPTOR AGONISTS - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat or to prevent anti-erythropoietin (EPO) antibody-mediated disorders such as pure red cell aplasia (PRCA) that are characterized by anti-EPO antibodies. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided. | 08-20-2009 |
20090221510 | ERYTHROPOIETIN RECEPTOR PEPTIDE FORMULATIONS AND USES - The present invention relates to novel uses of peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to methods of using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production, including chemotherapy induced anemia. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided. Also provided are kits and articles of manufacture comprising such compounds. | 09-03-2009 |
20130079283 | Erythropoitein Receptor Peptide Formulations and Uses - The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention also relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, and dosages are also provided. | 03-28-2013 |
Anne-Marie Edwards, Surrey GB
Patent application number | Description | Published |
---|---|---|
20150329529 | CARBOXAMIDE DERIVATIVES - The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; | 11-19-2015 |
20150329549 | CARBOXAMIDE DERIVATIVES - The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof; | 11-19-2015 |
Anne-Marie Frelin, Caen FR
Patent application number | Description | Published |
---|---|---|
20110186740 | SYSTEM FOR CONTROLLING PHOTOMULTIPLIER GAIN DRIFT AND ASSOCIATED METHOD - A system for controlling photomultiplier gain drift is disclosed. According to one aspect, the system includes first means for measuring a noise signal of the photomultiplier, the first means configured emit a measurement signal representative of the photomultiplier's noise signal. The system further includes second means for maintaining the measured noise signal at a constant level, based on the measurement signal. The disclosed embodiments apply to stabilization of the gain of photomultipliers and, more specifically, to stabilization of neutron measurement systems using photomultipliers. | 08-04-2011 |
Anne-Marie Goethals, Oud-Heverlee BE
Patent application number | Description | Published |
---|---|---|
20080229273 | SYSTEMS AND METHODS FOR UV LITHOGRAPHY - A method of designing a lithographic mask for use in lithographic processing of a substrate is disclosed. The lithographic processing comprises irradiating mask features of a lithographic mask using a predetermined irradiation configuration. In one aspect, the method comprises obtaining an initial design for the lithographic mask comprising a plurality of initial design features having an initial position. The method further comprises applying at least one shift to at least one initial design feature and deriving there from an altered design so as to compensate for shadowing effects when irradiating the substrate using a lithographic mask corresponding to the altered design in the predetermined irradiation configuration. Also disclosed herein are a corresponding design, a method of setting up lithographic processing, a system for designing a lithographic mask, a lithographic mask, and a method of manufacturing it. | 09-18-2008 |
20080315125 | METHOD AND SYSTEM FOR MEASURING CONTAMINATION OF A LITHOGRAPHICAL ELEMENT - A method and system for measuring contamination of a lithographic element is disclosed. In one aspect, the method comprises providing a first lithographical element in a process chamber. The method further comprises providing a second lithographical element in the process chamber. The method further comprises covering part of the first lithographical element providing a reference region. The method further comprises providing a contaminant in the process chamber. The method further comprises redirecting an exposure beam via the test region of the first lithographical element towards the second lithographical element whereby at least one of the lithographical elements gets contaminated by the contaminant. The method further comprises measuring the level of contamination of the at least one contaminated lithographical element in the process chamber. | 12-25-2008 |
20090103069 | DETECTION OF CONTAMINATION IN EUV SYSTEMS - A sensor for sensing contamination in an application system is disclosed. In one aspect, the sensor comprises a capping layer. The sensor is adapted to cause a first reflectivity change upon initial formation of a first contamination layer on the capping layer when the sensor is provided in the system. The first reflectivity change is larger than an average reflectivity change upon formation of a thicker contamination layer on the capping layer and larger than an average reflectivity change upon formation of an equal contamination on the actual mirrors of the optics of the system. | 04-23-2009 |
20120099092 | DETECTION OF CONTAMINATION IN EUV SYSTEMS - A sensor for sensing contamination in an application system is disclosed. In one aspect, the sensor comprises a capping layer. The sensor is adapted to cause a first reflectivity change upon initial formation of a first contamination layer on the capping layer when the sensor is provided in the system. The first reflectivity change is larger than an average reflectivity change upon formation of a thicker contamination layer on the capping layer and larger than an average reflectivity change upon formation of an equal contamination on the actual minors of the optics of the system. | 04-26-2012 |
Anne-Marie Gosnet-Haghiri, Sceaux FR
Patent application number | Description | Published |
---|---|---|
20130071305 | METHOD FOR MANUFACTURING A MICROFLUIDIC CHIP, AND RELATED CHIP AND PLATE - The invention relates to a method for manufacturing a microfluidic chip, wherein said method comprises the steps of: providing a plate combined with a layer of inorganic silica gel of formula: (HsiO | 03-21-2013 |
Anne-Marie Gue, Rebigue FR
Patent application number | Description | Published |
---|---|---|
20090200165 | USE OF POLYMER REAGENTS TO MODULATE AND CONTROL ELECTROKINETIC FLOWS IN A MICRO- OR NANOFLUIDIC DEVICE - The invention concerns the field of microfluidics and in particular that of electrophoresis on a micro- or nanofluidic device. More particularly, the invention concerns the use of a reactive polymer coating adapted to be submitted to a phase separation under the influence of an external stimulation of chemical or physical type, to modulate the electrokinetic flows (electroosmotic or electrophoretic flows during electrophoresis for example) in a micro- or nanofluidic device. The invention also concerns a method for varying the electrokinetic flows in such a device using said coating, as well as the micro- or nanofluidic devices comprising at least one channel or one capillary tube whereof the inner surface is covered at least partly with such a coating. | 08-13-2009 |
Anne-Marie Haghiri-Gosnet, Sceaux FR
Patent application number | Description | Published |
---|---|---|
20130092211 | ASYMMETRIC MIM TYPE ABSORBENT NANOMETRIC STRUCTURE AND METHOD FOR PRODUCING SUCH A STRUCTURE - According to one aspect, the invention relates to an asymmetric MIM type absorbent nanometric structure ( | 04-18-2013 |
Anne-Marie Hissel, Belfort FR
Patent application number | Description | Published |
---|---|---|
20140132227 | REGULATION METHOD - The invention relates to a method for automatic regulation of a system in which a plurality of parameters characteristic of the system are measured and in which at least one control parameter (u) is applied as a function of the measured parameters (y). The method includes choosing a nominal operating point of the system, and defining a nominal model (Mn) of the system at this nominal operating point. The method further includes determining a set of representative models ([Mk]) of the possible variations relative to the nominal model (Mn) and parameterizing the error of the nominal model (Mn) of the system by decomposition ([δ | 05-15-2014 |
20140136003 | REGULATION METHOD - The invention relates to a method for automatic regulation of a system in which a plurality of parameters characteristic of the system are measured and in which at least one control parameter (u) is applied as a function of the measured parameters (y). The method includes choosing a nominal operating point of the system, and defining a nominal model (Mn) of the system at this nominal operating point is determined, and estimated characteristic output parameters (y | 05-15-2014 |
Anne-Marie Lambeir, Wilrijk BE
Patent application number | Description | Published |
---|---|---|
20140079632 | ACTIVITY-BASED PROBES FOR THE UROKINASE PLASMINOGEN ACTIVATOR - The present invention relates to selective trypsine-like serine protease activity-based probes, in particular urokinase plasminogen activator-activity based probes, the use thereof and methods for detecting selective urokinase activity by making use of said probes. | 03-20-2014 |
Anne-Marie Lanteigne, Laval CA
Patent application number | Description | Published |
---|---|---|
20130224266 | IMMUNOGENIC COMPOSITION - The present invention relates to the use of a immunogenic or immunostimulatory composition comprising a | 08-29-2013 |
Anne-Marie Lezoray, Villeconin FR
Patent application number | Description | Published |
---|---|---|
20100285076 | FLUID COSMETIC COMPOSITION COMPRISING A MONOALCOHOL - The present invention relates to the field of making up and/or caring for the skin and is targeted in particular at providing a fluid care and/or make-up cosmetic composition in the form of a water-in-oil emulsion dedicated to the skin comprising a fatty phase, an aqueous phase and at least one dimethicone copolyol, the aqueous phase forming 40 to 60% by weight, with respect to the total weight of the said composition, and comprising at least 5% by weight, with respect to the total weight of the composition, of at least one C | 11-11-2010 |
20130129652 | COLORED AQUEOUS COSMETIC COMPOSITIONS - The present invention relates to a cosmetic care and/or makeup composition comprising at least 65% by weight relative to its total weight of an aqueous phase, at least 2% by weight relative to its total weight of pigments in the form of pigmentary particles that are dispersed and/or dispersible in aqueous medium, at least one water-soluble or water-dispersible gelling agent in a content ranging from 0.05% to 40% by weight relative to the total weight of the composition, and at least one polyol containing from 3 to 12 carbon atoms, said composition having a viscosity at least equal to 600 Pa·s at a shear of 0.010 s—and less than 0.8 Pa·s at a shear of 1000 s—, and said pigmentary particles being first formed from an intimate mixture of said pigments and from at least one polyol. | 05-23-2013 |
Anne-Marie Lienhardt, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20110241591 | DEVICE WITH A POLYPHASE ELECTRICAL MACHINE, AND RELATED ELECTRICAL MACHINE - The invention relates to a device having a polyphase electrical machine, wherein a plurality of inverters ( | 10-06-2011 |
Anne-Marie Lompre, Evry FR
Patent application number | Description | Published |
---|---|---|
20100278809 | Inhibitors of MRP4 for the Treatment of Vascular Disorders - The invention relates to inhibitors of MRP4 for the treatment and/or the prevention of vascular disorders such as atherosclerosis, post-angioplasty restenosis, pulmonary arterial hypertension or vein-graft disease. | 11-04-2010 |
Anne-Marie Lompre, Paris FR
Patent application number | Description | Published |
---|---|---|
20110150862 | INHIBITORS OF STIM1 FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS - The invention relates to inhibitors of STIM1 for the treatment and/or the prevention of cardiac disorders such as atherosclerosis, post-angioplasty restenosis, pulmonary arterial hypertension, vein-graft disease, cardiac hypertrophy, cardiac arrhythmias, valvulopathies, diastolic dysfunction, chronic heart failure, ischemic heart failure, and myocarditis. | 06-23-2011 |
20110218232 | Inhibitors of MRP4 and Agents Stimulating MRP4 Activity for the Treatment of Cardiac Disorders - The invention relates to inhibitors of Multi drug Resistant Protein 4 (MRP4) for the treatment and/or the prevention of cardiac disorders, such as acute or chronic heart failure and cardiogenic shock. The invention also relates to agents stimulating MRP4 activity for the treatment and/or the prevention of cardiac hypertrophy. | 09-08-2011 |
Anne-Marie Mariotte, Saint Simeon De Bressieux FR
Patent application number | Description | Published |
---|---|---|
20110237551 | Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use in Cosmetic or Dermatological Compositions - The invention relates to the use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions, specifically to the use of at least one compound derived from para-coumaric acid having a general formula (I) below: | 09-29-2011 |
20130272983 | Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and their Use in Cosmetic or Dermatological Compositions - The invention relates to the use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions, specifically to the use of at least one compound derived from para-coumaric acid having a general formula (I) below: | 10-17-2013 |
Anne-Marie Meadon, Midrand ZA
Patent application number | Description | Published |
---|---|---|
20110173976 | ENERGY GENERATING SYSTEM USING A PLURALITY OF WATERWHEELS - An energy generating system is provided, comprising a primary waterwheel for receiving water from a head penstock or upper pumping setup, the primary waterwheel comprising a plurality of radial arms rotatable about a primary axis, the radial arms terminating in water scoops for accommodating the water from the head penstock or upper pumping setup, the primary waterwheel defining head height. The system further comprises at least one additional waterwheel located within the head height of the primary waterwheel, the additional waterwheel also comprising a plurality of radial arms rotatable about an axis, the radial arms terminating in water scoops for accommodating either excess water from the head penstock or upper pumping setup or water that has spilled out of the water scoops of the primary waterwheel. In an example embodiment, the primary waterwheel and the at least one additional waterwheel are vertically orientated. In an example embodiment, the at least one additional waterwheel is smaller than the primary waterwheel. | 07-21-2011 |
Anne-Marie Mes-Masson, Dollard Des Ormeaux CA
Patent application number | Description | Published |
---|---|---|
20080248501 | Methods of Diagnosing Ovarian Cancer and Kits Therefor - A method for the diagnosis of ovarian cancer comprising providing a biological sample from a subject (subject sample), and detecting the expression level of each of the markers FGF-2, CA 125 and IL-18 in the subject sample A kit comprising means for detection of an expression level of each of the markers CA 125, FGF-2 and IL-18 in a biological sample from a subject (subject sample), and instructions to use said markers in a method of the present invention. | 10-09-2008 |
20090123932 | QUANTITATIVE TEST TO DETECT DISEASE PROGRESSION MARKERS OF EPITHELIAL OVARIAN CANCER PATIENTS - The present invention concerns a method of prognosing the risk of early ovarian cancer relapse in a subject having ovarian cancer comprising: a) detecting the level of at least one marker selected from the group consisting of BTF4, GCS and HLA-DRbeta1; and b) comparing the level of the above at least one marker with that of a corresponding control sample, wherein the detection of a lower level of the at least one marker compared to that in the control sample is indicative that the subject is at risk of early cancer relapse. Also provided is a method of stratifying a subject suffering from ovarian cancer based on the expression levels of the disclosed markers and kits for practicing the methods of the present invention. | 05-14-2009 |
Anne-Marie Mihailescu, Melsungen DE
Patent application number | Description | Published |
---|---|---|
20160058936 | RECIRCULATION DEVICE OF AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS - A recirculation device of an extracorporeal blood treatment device is disclosed with a preferably universal medical fluid container to which an arterial line section of a fluid conducting system of the extracorporeal blood treatment device can be connected as an option. Furthermore, the recirculation device has a 3-way switch, preferably a 3-way valve, which is arranged directly downstream of the universal medical fluid container. A conduit of the 3-way switch is preferably coupled with a spike or a similar connecting device or is formed in one piece together with it. | 03-03-2016 |
Anne-Marie Mihilescu, Melsungen DE
Patent application number | Description | Published |
---|---|---|
20160058935 | FILLING DEVICE OF A FLUID SYSTEM - A filling device of a fluid conducting system of an extracorporeal blood treatment device is disclosed. The filling device includes a spike that is adapted for connection to a single fluid connector of a medical fluid container of the fluid system and a manually operable fluid blocking mechanism that is arranged directly downstream of the spike and is adapted or provided in such a way so as to remain fluidly connected with the spike while the filling device is in operation. The fluid blocking mechanism has at least one fluid outlet connector that is adapted so that a line section or hose of the fluid conducting system, preferably an arterial line section of a blood purification device, can be connected to it in a detachable manner while the filling device is in operation. | 03-03-2016 |
Anne-Marie Milcent, Lyon FR
Patent application number | Description | Published |
---|---|---|
20150224248 | ASSEMBLY FOR INJECTING A VISCOUS LIQUID PRODUCT - The present invention relates to an assembly for medical use comprising: | 08-13-2015 |
Anne-Marie Praden, Meudon FR
Patent application number | Description | Published |
---|---|---|
20150149765 | METHOD OF ANONYMIZATION - This invention is aimed at a method for the anonymisation of data that could help identify the user while a profile of said user is collected by a targeting data collection server. To implement such anonymisation, an anonymisation server is placed between a user terminal and the collections server. The profile data collected are encrypted by the terminal using a secret key shared with the data collection server. Those profile data supplemented with data that could help identify the user are then sent to the anonymisation server. The anonymisation server encrypts the data that could help identify the user with an anonymisation key of said anonymisation server before sending on the encrypted collected data and the anonymised identification data to said collection server. | 05-28-2015 |
Anne-Marie Praden, Ventabren FR
Patent application number | Description | Published |
---|---|---|
20080271103 | Controlling Access to Broadcast Services in a Terminal Device - Services are distributed via a distribution network to terminal devices. One of the services is an electronic service guide stored in the terminal devices and providing descriptive data on the distributed services. To control access to the services distributed to a terminal device, the device includes a module for filtering descriptive data on the distributed services in accordance with at least one filtering criterion, and a graphics module for displaying the filtered descriptive data that meets the filtering criterion so as to enable services associated with the displayed filtered descriptive data to be selected. | 10-30-2008 |
20090328099 | BROADCAST SYSTEM WITH A LOCAL ELECTRONIC SERVICE GUIDE GENERATION - A broadcast system includes a terminal system having a display module for displaying an Electronic Service Guide (ESG) of programs to be broadcasted. The ESG initiates the storing of a program selected through such ESG and broadcasted to the terminal system. The broadcast system includes a module for creating and displaying a local ESG on the terminal system. This local ESG corresponds to programs which have been selected, broadcasted and stored in the terminal system. The local ESG launches the rendering of a stored program in response to actuating a corresponding item in the local ESG. | 12-31-2009 |
20100306795 | SUBSCRIBER IDENTITY MODULE AND ASSOCIATED BROADCASTING SERVER ADAPTED FOR MANAGING PROGRAMS HAVING UNDEFINED DURATION - The invention relates to a value-added service applied to the broadcasting of video programs or content and more particularly to mobile television (Mobile TV). The invention promotes service continuity during the broadcasting of programs having an undefined duration and the broadcasting of which has been subject to a Pay-Per-View type purchase. | 12-02-2010 |
20100319022 | PERSONALIZED VIDEO SEGMENT IN BROADCAST WORLD - A personal mobile TV system (T, CP) stores an end-user profile, and it stores and runs a content personalization program controlling the system into automatic selection of a video segment source (BN | 12-16-2010 |
20110185377 | METHOD FOR ACCESSING A SERVICE OFFERED FROM A TOKEN, CORRESPONDING TOKEN AND SYSTEM - The invention relates to a method for accessing a service offered from a token. The token is coupled with a terminal. The terminal is capable of receiving broadcast messages. The messages are broadcasted from at least one server. According to the invention, the server sends, through the terminal, within the broadcast messages, at least one piece of data intended for the token and executable by the token. The token executes the executable data by triggering an execution of an application embedded at least in part within the token. The invention relates also to a corresponding token and system. | 07-28-2011 |
20130007784 | METHOD FOR CONTROLLING AN AUDIENCE MEASUREMENT RELATING TO BROADCAST DATA, CORRESPONDING CONTROLLER, DEVICE AND SYSTEM - The invention relates to a method for controlling an audience measurement relating to broadcast data. According to the invention, the method comprises the following steps: an information sending step in which a server sends to at least one device at least one piece of information for disallowing an execution of an audience measurement relating to at least one piece of identified content data that is broadcast or to be broadcast; and an audience measurement stopping step in which the device stops an audience measurement relating to the identified content data. The invention also relates to corresponding server, device and system for controlling an audience measurement relating to broadcast data. | 01-03-2013 |
Anne-Marie Praden, Ventabrent FR
Patent application number | Description | Published |
---|---|---|
20090006584 | Service Personalization in a Terminal Device - Two service signals are transmitted from a service server through a first network in such a way that users' terminal devices display personalized service data items. When service signals are filtered, a terminal device extracts common data items accessible for several terminal devices and a parameter type from a service signal identified by a stored identifier. An end address is determined by applying a stored parameter, related to the parameter type, to a pre-recorded or transmitted algorithm. The end address is transmitted, through a second network, to a server which transmits a first personalized file associated with the end address and bearing personalized data items displayed with the common data items in the device. | 01-01-2009 |
Anne-Marie Prins, Herselt BE
Patent application number | Description | Published |
---|---|---|
20090264567 | Stabilized Cross-Linked Polyolefin Compositions - A composition is disclosed that includes at least one polyolefin, at least one organic peroxide, and an antioxidant mixture of a composition of at least one polyolefin, at least one organic peroxide, and an antioxidant mixture. The antioxidant mixture has at least one fast radical scavenger selected from the group consisting of low hindered phenols, low hindered thiophenols, low hindered thiobisphenols, aliphatic amines, aromatic amines, NOR HALS, hydroxylamines, and mixtures thereof, and at least one long term stabilizer selected from the group consisting of low hindered phenols, highly hindered phenols, thiosynergists, aliphatic amines, aromatic amines, HALS, hydroxylamines, and mixtures thereof. The preferred polyolefin is a homopolymer of ethylene or a copolymer of ethylene and the compositions are useful in insulating media for medium and high voltage wire and cable applications. | 10-22-2009 |
Anne-Marie Pulichino, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20110263681 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 10-27-2011 |
20120115933 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 05-10-2012 |
20120115934 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 05-10-2012 |
20120122960 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 05-17-2012 |
20130012571 | Organic Compositions to Treat Beta-ENaC-Related Diseases - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 01-10-2013 |
20140107179 | ORGANIC COMPOSITIONS TO TREAT Beta-ENaC-RELATED DISEASES - The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 04-17-2014 |
20150275218 | Organic Compositions to Treat Beta-ENaC-Related diseases - The present disclosure relates to RNAi agents useful in methods of treating BetaENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC. | 10-01-2015 |
Anne-Marie Rasmussen, Oslo NO
Patent application number | Description | Published |
---|---|---|
20100068193 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS - Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed. | 03-18-2010 |
20100129340 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS - Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed. | 05-27-2010 |
20130164312 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS - Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed. | 06-27-2013 |
20160024470 | METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS - Methods are disclosed for the generation of immunosuppressive regulatory T cells. The methods can include contacting a population of CD4+CD25− T cells with a T cell receptor (TCR)/CD3 activator, a TCR co-stimulator activator, and rapamycin. Kits for the generation of immunosuppressive regulatory T cells, methods of use, and cell populations are also disclosed. | 01-28-2016 |
Anne-Marie Riquet, Gif Sur Yvette FR
Patent application number | Description | Published |
---|---|---|
20100210725 | COPOLYMER-GRAFTED POLYOLEFIN SUBSTRATE HAVING ANTIMICROBIAL PROPERTIES AND METHOD FOR GRAFTING - A method for grafting a copolymer onto a polyolefin substrate includes the following steps: | 08-19-2010 |
Anne-Marie Schmitt-Milas, Tournefeuille FR
Patent application number | Description | Published |
---|---|---|
20090239934 | Anti-Myosin Va siRNA and Skin Depigmentation - The present invention relates to novel isolated siRNAs comprising a sense RNA strand and a complementary antisense RNA strand which together form an RNA duplex, characterized in that the sense RNA strand comprises a sequence which has at most one nucleotide that is distinct in relation to a fragment of 14 to 30 contiguous nucleotides of the nucleotide sequence of exon F of the gene encoding the myosin Va protein, and also to compositions comprising at least one such siRNA, and to the use of at least one such siRNA as a cosmetic or therapeutic agent for skin depigmentation. | 09-24-2009 |
Anne-Marie Stomp, Moncure, NC US
Patent application number | Description | Published |
---|---|---|
20090282584 | EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEED - Methods, nucleic acid sequences, and transformed duckweed plant or duckweed nodule cultures for the expression and the secretion of biologically active polypeptides from genetically engineered duckweed are provided. Expression of recombinant polypeptides in duckweed is improved by modifying the nucleotide sequence of the expression cassette encoding the polypeptide for improved expression in duckweed. Recovery of biologically active polypeptides from duckweed is improved by linking the biologically active polypeptide to a signal peptide that directs the secretion of the polypeptide into the culture medium. | 11-12-2009 |
20120258491 | EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEED - Methods, nucleic acid sequences, and transformed duckweed plant or duckweed nodule cultures for the expression and the secretion of biologically active polypeptides from genetically engineered duckweed are provided. Expression of recombinant polypeptides in duckweed is improved by modifying the nucleotide sequence of the expression cassette encoding the polypeptide for improved expression in duckweed. Recovery of biologically active polypeptides from duckweed is improved by linking the biologically active polypeptide to a signal peptide that directs the secretion of the polypeptide into the culture medium. | 10-11-2012 |
Anne-Marie Templeman, Minyip AU
Patent application number | Description | Published |
---|---|---|
20110043014 | CAR SEAT FOR A CHILD - The invention concerns a child seat for a car with a rear passenger seat that divides a passenger cabin space and a rear storage space and that is foldable to provide access to the rear storage space from the passenger cabin space. The child seat comprises a seat for a child and a mounting that links the seat to the car. The mounting is operable to transfer the seat between the rear storage space and the passenger space for storage and for carrying a child, respectively. | 02-24-2011 |
Anne-Marie T. Karp, Orleans, LA US
Patent application number | Description | Published |
---|---|---|
20130210777 | Amelioration of the Appearance of Bruises - The present invention is directed to compositions and processes for their use that ameliorate the appearance of bruises, making them less cosmetically unappealing. The composition functions by acting both as a humectant and occlusive agent attracting water, returning the skin surface to a smooth state and holding water in place. The re-establishment of a homeostatic state in the skin results in a rapid dissipation of the negative cosmetic effects of the bruise on the skin. | 08-15-2013 |
Anne-Marie Tousch, Colombes FR
Patent application number | Description | Published |
---|---|---|
20100066761 | METHOD OF DESIGNATING AN OBJECT IN AN IMAGE - The present invention relates to a method of designating an object in an image. The method includes: designating a point inside the object in the image; segmenting the image into elementary regions; identifying an origin region to which the point belongs; constructing a graph of connectedness between the regions; calculating a function of membership in the object for the regions connected to the origin region, by combining various membership criteria; merging the origin region with its connected regions, a connected region being merged if the value of its membership function is greater than a predetermined threshold; wherein the steps of calculating membership functions of the connected regions and of merging is repeated for each new merged region until no merging is performed. One or more embodiments of the invention applies to image processing in order to perform the graphical designation of an object by an operation that is simple for a user. | 03-18-2010 |
20140003729 | METHOD FOR THE AUTOMATED EXTRACTION OF A PLANOGRAM FROM IMAGES OF SHELVING | 01-02-2014 |
Anne-Marie Ulmer-Moll, Rennes FR
Patent application number | Description | Published |
---|---|---|
20090129490 | Method and a Device for Dynamically Selecting Orthogonal Functions of an Orthogonal Transmission System - An interleaving method ( | 05-21-2009 |
20090274035 | Dynamic Interleaving Method and Device - An interleaving method ( | 11-05-2009 |
20100008214 | Interleaving with iterative calculation of interleaving addresses - A method and a device ( | 01-14-2010 |
20110002323 | DYNAMIC TIME INTERLEAVING METHOD AND AN ASSOCIATED DEVICE - The present invention relates to a time interleaving method ( | 01-06-2011 |
20120307921 | METHOD FOR SELECTING A TRANSMISSION MODE - A method and device are provided for selecting a transmission mode, for a first telecommunications entity having a plurality of different modes for transmitting a communications signal to a second telecommunications entity. The various transmission modes provide the same data rate D. The method includes: for a given transmission mode, determining the value of a first metric α that measures degradation relating to a given distance d stemming from the transmission medium of the communications signal for a given environment compared with a reference model for the transmission medium, as a result of a multi-path effect and/or of an attenuation effect of the transmission medium; and comparing values of the metric α for different modes in order to select at least one transmission mode. | 12-06-2012 |
20130154872 | METHOD AND A DEVICE FOR LOCATING AT LEAST ONE OBSTACLE IN A COMMUNICATIONS NETWORK, A CORRESPONDING COMPUTER PROGRAM - A method and apparatus are provided for locating an obstacle between a transmitter and a receiver. The method includes: determining at least one elliptical ring in which the obstacle is situated, the elliptical ring being defined by two confocal ellipses, having their focuses corresponding to the transmitter and to the receiver, each elliptical ring being associated with a physical echo generated by an obstacle; estimating a distance between the obstacle and a focus as a function of the separation between the confocal ellipses at the obstacle in a plane normal to the axis defined by the focuses so as to obtain a set of potential location zones for the obstacle in the elliptical ring; and lifting the ambiguity between the various potential location zones of the obstacle so as to deliver a location zone of the obstacle. | 06-20-2013 |
Anne-Marie Van Stiphoudt, Wavre BE
Patent application number | Description | Published |
---|---|---|
20120214925 | Organosiloxane Compositions - This invention relates to the use of silyl terminated organic polymers in phenylorganosiloxane based silicone sealant formulations containing silyl terminated organic polymers are described. Subsequent to cure the compositions, provide sealants exhibiting superior mechanical properties, particularly with respect to elongation, tensile strength and adhesion on glass. The composition comprises a phenylorganosiloxane having terminal groups selected from —OH or hydrolysable groups and unsaturated groups. Typically the phenylorganosiloxane has a viscosity of at least 10000 mPa.s at 25° C. Other ingredients include either: (i) one or more organic polymers having terminal and/or pendent silyl groups containing —OH functional groups or hydrolysable functional groups, or (ii) one or more organic polymers having terminal and/or pendent silyl groups containing one or more unsaturated groups, selected in accordance with the terminal groups of (a) as well as fillers, cross-linkers and catalyst. | 08-23-2012 |
Anne-Marie Vissac, Neuville Sur Oise FR
Patent application number | Description | Published |
---|---|---|
20100015647 | METHOD AND KIT FOR THE DETECTION OF HEPARIN-DEPENDENT ANTIBODIES AND THE DIAGNOSIS OF IMMUNE OR AUTOIMMUNE PAHTOLOGIES POTENTIATED BY HEPARIN SUCH AS HEPARIN-INDUCED THROMBOCYTOPENIA - The invention relates to a method for the detection of heparin-dependent antibodies and the diagnosis of immune or autoimmune pathologies potentiated by a heparin substance, such as thrombocytopenia induced by heparin (HIT type II) as inducer drug. The invention is characterized in that said method comprises the steps consisting in: 1) reacting: at least one substance with high affinity for a heparin substance (SFA), consisting of any molecule or complex having a high affinity for a heparin substance, with at least one heparin substance (SH) so as to form a substance with high affinity for heparin-heparin substance (SFA-SH) complex, wherein the heparin substance is in slight or large excess, so as to be able to bind other substances with affinity for heparin; then with at least one potential antigenic substance capable of reacting with the heparin substance, thus forming a complex (Ag-SH; and, finally, with the plasma or the serum of a patient to be tested (preferably diluted to a dilution of the order of 1:100) potentially containing: an anti(Ag-SH) antibody material generated in the organism after administration of a heparin substance, and/or at least one immune complex consisting of an Ag-SH/anti(Ag-SH) antibody complex present in the plasma or serum of the patient capable of reacting with the substance with high affinity for the heparin substance-heparin substance (SFA-SH) complex, and then, 2) revealing the resulting (Ag-SH)-anti(Ag-SH) complex produced. | 01-21-2010 |
Anne-Marie Zuurmond, Den Haag NL
Patent application number | Description | Published |
---|---|---|
20100035271 | Modification of Collagenous Materials and Medical Treatment, Diagnosis and Monitoring of Fibrotic Conditions - The present invention relates to the gene PLOD2 which codes for telopeptide lysyl hydroxylase (TLH). This enzyme converts telopeptidyl Lys into telopeptidyl Hyl, that can subsequently be converted into hydroxyallysine cross-links. Collagen with hydroxyallysine cross-links shows a higher resistance to degradation by proteinases than collagen with cross-links derived from allysine. | 02-11-2010 |